Trusted Resources: Education
Scientific literature and patient education texts
Normal Scores of Deep Breathing Tests: Beware of Dysrhythmia in Transthyretin Amyloidosis
source: Amyloid: The International Journal of Experimental and Clinical Investigation
year: 2018
authors: Wiklund U, Kadkhodaee A, Andersson K, Suhr OB, Hörnsten R
summary/abstract:Background:
The heart rate (HR) response to paced deep breathing (DB) is a common test of cardiac autonomic function, where high heart rate variability (HRV) is considered to reflect normal autonomic function. We evaluated the DB test in patients with hereditary transthyretin amyloid (ATTRm) amyloidosis, where autonomic dysregulation and atrial arrhythmias are common.
Methods:
Paced DB was performed during one minute (six breaths/min) in 165 recordings in adult ATTRm amyloidosis patients with the TTR Val30Met mutation, 42 hypertrophic cardiomyopathy (HCM) patients and 211 healthy subjects. HRV was scored by traditional DB indices and by a novel regularity index, estimating the fraction of the HRV that was coherent with the breathing pattern.
Results:
Twenty per cent of ATTRm amyloidosis patients presented with age-adjusted HRV scores within normal limits but poor regularity due to subtle atrial arrhythmias and cardiac conduction disturbances. Forty-seven per cent of ATTRm amyloidosis patients presented with HRV scores below normal limits, whereas HCM patients presented with higher HRV than ATTRm amyloidosis patients.
Conclusions:
Reduced HRV is common in ATTRm amyloidosis patients during DB, however, autonomic function cannot be evaluated in patients presenting with the combination of “normal” scores and low regularity, since their HR responses often reflects dysrhythmias.
organization: Umeå University, SwedenDOI: 10.1080/13506129.2018.1434140
read more full text
Related Content
-
Alnylam Clinical Trial Update – ASG Webinar 4/11https://www.youtube.com/watch?v=K2TmwAfu...
-
Pathophysiology and Treatment of Cardiac AmyloidosisAmyloid cardiomyopathy should be suspect...
-
CRISPR Gene Editing Reduces Disease-Causing Protein in Hereditary Transthyretin AmyloidosisThe results of the phase 1 study open-la...
-
Transthyretin Cardiac Amyloidosis (ATTR-CM) Signs, Symptoms, and Diagnostic Approach – ASG Webinar 1/11https://www.youtube.com/watch?v=K2TmwAfu...
-
Hereditary ATTR Thr60Ala AmyloidosisHereditary ATTR amyloidosis is an inheri...
-
Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid CardiomyopathyBackground: Tafamidis is approved in ma...
-
Hereditary Transthyretin AmyloidosisHereditary transthyretin (ATTR) amyloido...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.